Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Fleming

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
The Oncologist|April 19, 2022
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial CarcinomaTomi Jun, Noah M Hahn, Guru Sonpavde, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|February 1, 2015
Screen for alterations of iron related parameters in N-ethyl-N-nitrosourea-treated mice identified mutant lines with increased plasma ferritin levelsBirgit Rathkolb, Martina Klempt, Sibylle Sabrautzki, et al.
Glia|July 23, 2019
Role of a Contactin multi-molecular complex secreted by oligodendrocytes in nodal protein clustering in the CNSAnne-Laure Dubessy, Elisa Mazuir, Quentin Rappeneau, et al.
The Lancet. Oncology|May 29, 2025
Health-related quality of life, pain, and symptomatic skeletal events with [<sup>177</sup>Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trialKarim Fizazi, Michael J Morris, Neal D Shore, et al.
Future Oncology (London, England)|May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinomaMatthew D Galsky, Alexandra Drakaki, Arnab Basu, et al.
Pediatric Blood & Cancer|August 11, 2020
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy ConsortiumMichael A Pulsipher, Leslie E Lehmann, Alison A Bertuch, et al.
American Journal of Human Genetics|April 10, 2025
Advancing precision care in pregnancy through a treatable fetal findings listJennifer L Cohen, Michael Duyzend, Sophia M Adelson, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
The New England Journal of Medicine|July 25, 2019
Erdafitinib in Locally Advanced or Metastatic Urothelial CarcinomaYohann Loriot, Andrea Necchi, Se Hoon Park, et al.
The New England Journal of Medicine|August 17, 2012
Increased survival with enzalutamide in prostate cancer after chemotherapyHoward I Scher, Karim Fizazi, Fred Saad, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
The Oncologist|April 19, 2022
Phase II Clinical and Translational Study of Everolimus ± Paclitaxel as First-Line Therapy in Cisplatin-Ineligible Advanced Urothelial CarcinomaTomi Jun, Noah M Hahn, Guru Sonpavde, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|February 1, 2015
Screen for alterations of iron related parameters in N-ethyl-N-nitrosourea-treated mice identified mutant lines with increased plasma ferritin levelsBirgit Rathkolb, Martina Klempt, Sibylle Sabrautzki, et al.
Glia|July 23, 2019
Role of a Contactin multi-molecular complex secreted by oligodendrocytes in nodal protein clustering in the CNSAnne-Laure Dubessy, Elisa Mazuir, Quentin Rappeneau, et al.
The Lancet. Oncology|May 29, 2025
Health-related quality of life, pain, and symptomatic skeletal events with [<sup>177</sup>Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trialKarim Fizazi, Michael J Morris, Neal D Shore, et al.
Future Oncology (London, England)|May 16, 2026
TROPION-Urothelial03: a phase II/III study of datopotamab deruxtecan (Dato-DXd) for locally advanced or metastatic urothelial carcinomaMatthew D Galsky, Alexandra Drakaki, Arnab Basu, et al.
Pediatric Blood & Cancer|August 11, 2020
A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy ConsortiumMichael A Pulsipher, Leslie E Lehmann, Alison A Bertuch, et al.
American Journal of Human Genetics|April 10, 2025
Advancing precision care in pregnancy through a treatable fetal findings listJennifer L Cohen, Michael Duyzend, Sophia M Adelson, et al.
Nature Medicine|July 10, 2010
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemiaMichael G Kharas, Christopher J Lengner, Fatima Al-Shahrour, et al.
The New England Journal of Medicine|July 25, 2019
Erdafitinib in Locally Advanced or Metastatic Urothelial CarcinomaYohann Loriot, Andrea Necchi, Se Hoon Park, et al.
The New England Journal of Medicine|August 17, 2012
Increased survival with enzalutamide in prostate cancer after chemotherapyHoward I Scher, Karim Fizazi, Fred Saad, et al.
Pageof 10